NTRA

Natera
D

NTRA

156.660
USD
5.24
(3.46%)
مغلق
حجم التداول
56,601
الربح لكل سهم
-2
العائد الربحي
-
P/E
-102
حجم السوق
21,298,250,033
أصول ذات صلة
G
GH
-2.020
(-4.13%)
46.900 USD
HOLX
HOLX
-3.060
(-5.35%)
54.180 USD
ILMN
ILMN
1.395
(1.82%)
77.905 USD
M
MYGN
0.42000
(5.88%)
7.56000 USD
PODD
PODD
6.88
(2.75%)
257.00 USD
Q
QGEN
0.880
(2.08%)
43.110 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
VEEV
VEEV
4.350
(1.88%)
236.310 USD
المزيد
الأخبار المقالات

العنوان: Natera

القطاع: Healthcare
الصناعة: Diagnostics & Research
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.